RAD51 and nasopharyngeal carcinoma: To confirm that RAD51 is the mediator of radiotherapy resistance induced by circCDYL2, we simultaneously overexpressed circCDYL2 and knocked down RAD51 in nasopharyngeal carcinoma cells.